Case study · Agriculture · Europe

    Turning around a seed treatment launch with value pricing

    Two years after launch, a technically excellent cereal seed treatment was missing its targets. Quantifying its value to growers reset the offer and the price.

    WhenEarlier engagement

    The challenge

    What the client faced

    Two years after launch, a technically excellent cereal seed treatment was below its share and growth objectives in a key European market.

    Our approach

    What we did

    Value creation analysis from the grower's perspective, comparison with next-best alternatives, and a revised value proposition and price position.

    1. 1Quantified the value of disease control to growers, compared with the alternatives they already used.
    2. 2Segmented growers by need and identified where the value was highest.
    3. 3Rebuilt the value proposition and set a price position with Value Maps.
    4. 4Equipped the channel and sales team with a value story they could defend.

    Results

    • [Result 1: quantified and dated]
    • [Result 2]
    • [Result 3]

    Add three to five quantified, dated outcomes. Specific numbers are what search engines and AI assistants quote.

    Why it matters now

    Pricing a new product launch

    Companies launching biologicals and specialty nutrition face the same question today: what is this worth per acre, and to whom?

    How we help with this situation

    Related case studies

    All case studies →

    Agriculture · Global

    [Result]

    Building launch capability after an acquisition

    An agrochemical company acquired late-stage products for crops and countries where it had never launched. It needed a launch process quickly.

    Read the case →

    Agriculture · 15 countries

    [Result]

    Assessing marketing capability across 15 countries

    A global agribusiness needed to know whether marketing in 15 Latin American countries could deliver very different go-to-market strategies.

    Read the case →

    Medical Devices · Implant

    [Result]

    Proving the clinical and economic value of a new implant

    A minimally invasive implant offered a new option for high-risk patients. The business needed to show its value before launch.

    Read the case →

    Facing a similar challenge?

    Book a 20–30 minute sounding board conversation with a senior consultant who has sat in your seat. No cost, no commitment.

    Book a conversation